EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

BioQuest Corp (BQST) fair value: what the stock is really worth

We calculate from audited financials what BioQuest Corp is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.

Valuation from Jun 24, 2026. With the latest figures (losses, negative cash flow), a fair value can no longer be calculated.
  1. Fair value above price? No
  2. Good quality? No
  3. Add to watchlist

Financial Services · US

BC BioQuest Corp logo Thin data Jun 24, 2026

BioQuest Corp

BQST · US

Weakest SetupStrongly overvalued and low quality.

!Fair value $0.0300 · Strongly overvalued (−55%)
!Quality 31/100
!Weak Growth
!negative free cash flow
!Mixed vs. peers (3/7)
!Narrow moat 12/100
!Evidence only low, so the estimate is less certain
Watch BioQuest Corp for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card. Watch for free Pro now: $1 first month

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$1.94 $0.0227 Fair Value $0.0300 Jun 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jun 24, 2026.

How to read this chart

60‑month range $0.0227 – $1.94 · fair‑value band $0.0200 – $0.0400 · the $0.0670 price screens above the $0.0300 fair value. Dashed = 300-day average. As of Jun 24, 2026.

Follow BioQuest in your weekly email

Every Wednesday you see whether BioQuest is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

BioQuest Corp. develops and offers AI-powered voice and chat solutions to help organizations automate communication, enhance engagement, and reduce operational costs. It serves a range of industries, including nonprofits and ministries. The company is based in Katy, Texas.

Stock analysis

BioQuest Corp (BQST) currently trades at $0.0670, while our model-based Fair Value estimate is $0.0300, implying the stock looks roughly 123.3% overvalued today.

Show more

Valuation

How firm this estimate is: it rests on 2 models at a data quality of 91/100, which puts the evidence level at low.

Scenario range: $0.0200 (bear) to $0.0400 (bull), the price of $0.0670 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 31/100 (below-average quality), in the Financial Services sector.

Weak Growth: Revenue growth is weak, negative or inconsistent.

BioQuest Corp reported revenue of $144K in FY2025 versus $0 in FY2020. Reported net income was −$781K in FY2025.

Key figures

Market cap $2.0M · P/S ratio 63.7 · Return on assets (EBIT) −34,731% · Free cash flow −$746K · Net debt $386K.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 22 out of 100 (low confidence).

What moves the price

The share trades about 93% below its 52-week high and 2% above its 52-week low.

For context, the median of 10 Financial Services peers we cover trades at −53% fair-value upside, at −55%, BQST screens richer than that median.

Fair Value models

Bear $0.0200 Fair Value $0.0300 Bull $0.0400
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
NCAV (Graham) n/a n/a $0.0100 48
All 1 models by family
Asset-Based
NCAV (Graham) n/a n/a $0.0100 48

Open the full fair value analysis →

Notify me when BQST reaches fair value

Put BQST on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 31/100

Of which business quality 32 · Market factors (momentum, volatility) 8

Profitability 1
Margins and returns on capital today
Quality Growth 50
Are margins and returns improving?
Cashflow 33
Earnings quality: real cash, not paper profit
Fin. Strength 29
Balance sheet, leverage, solvency risk
Investment 50
Disciplined investing over empire-building
Low Volatility 0
Calm price path (market factor)
Momentum 17
Price trend over the last 3–12 months (market factor)
52W Momentum 0
Distance to the 52-week high (market factor)
Net Issuance 48
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 0/100
Revenue growth is weak, negative or inconsistent.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

BQST screens 123% overvalued. Compare with Lionheart III Corp →

Compare BioQuest Corp with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Shell Companies · 80 stocks

Beats the industry median on 2/5 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 32 · Bottom 25%
Fair Value upside −55% · Below median
Profitability
Operating margin (TTM) 0% · Top 25%
Growth and dividend
Revenue growth 0% · Top 25%

Valuation Multiplesvs Shell Companies median · lower = cheaper

P/B 9.78× · book value is mostly goodwill ⓘGoodwill and other intangible assets are larger than the equity. The book value mainly reflects prices paid for past acquisitions, so we do not rank this P/B against the peer group.
P/S (TTM) 63.70× · Priciest 25%

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Shell Companies stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Lionheart III Corp LION $11.36 $15.02 +32%
AA Mission Acquisition Corp AAM $0.0360 $0.0490 +36%
Berto Acquisition Corp TACO $10.46 $2.73 −74%
Metals Acquisition Corp MTAL $10.16 $20.32 +100%
Axiom Intelligence Acquisition Corp AXIN $10.33 $1.71 −83%
Bold Eagle Acquisition Corp BEAG $10.82 $4.00 −63%
Lionheart Holdings CUB $10.88 $5.06 −53%
Texas Ventures Acquisition III Corp TVACW $0.2210 $0.2600 +18%
Translational Development Acquisition Corp TDAC $10.86 $4.28 −61%
TGE Value Creative Solutions Corp BEBE $10.04 $3.58 −64%

Explore undervalued stocks

More undervalued Financial Services stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Calculator with industry benchmark Peter Lynch Fair Value Formula &…Calculator with industry benchmark
Run the numbers yourself: free valuation calculators
DCF CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorFama-French ModelIntrinsic Value
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

BioQuest Corp · Fair Value
$0.0300 −123%Fair Value
Calculator →

Cite: Fair Value Calculator (2026). "BioQuest Corp Fair Value". https://www.fairvalue-calculator.com/stock/BQST

Frequently asked questions

Is BioQuest Corp (BQST) overvalued or undervalued?
As of Jun 24, 2026, our model estimates a fair value of $0.0300 versus the last price from Sep 18, 2026 of $0.0670, about −55% upside (overvalued).
What is the fair value of BQST?
Our model-based fair value for BioQuest Corp is $0.0300 (as of Jun 24, 2026), built from audited fundamentals. Last price (from Sep 18, 2026): $0.0670.
What is the quality score of BQST?
BioQuest Corp has a Quality Score of 31/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for BioQuest Corp (BQST)?
Our model-based price target is the fair value of $0.0300 (as of Jun 24, 2026) from 1 valuation models. Cautious scenario $0.0200, optimistic scenario $0.0400. It is a calculation from audited fundamentals, not an analyst target.
What is the BioQuest Corp stock forecast for 2026?
Our models put fair value at $0.0300, about −55% upside versus the last price from Sep 18, 2026 of $0.0670 (overvalued). Cautious scenario $0.0200, optimistic scenario $0.0400. The calculation is refreshed regularly with new filings.
What is the intrinsic value of BioQuest Corp (BQST)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For BioQuest Corp it is $0.0300 per share (as of Jun 24, 2026), against a price of $0.0670. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is BioQuest Corp stock overvalued or undervalued in 2026?
As of Jun 24, 2026, BQST trades above its calculated fair value: price $0.0670, fair value $0.0300, a gap of about −55% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of BQST?
No. The price is what the market pays today ($0.0670); the fair value is what the company's own numbers justify ($0.0300). For BioQuest Corp the two are $0.0370 per share apart. That gap is exactly why we show both numbers side by side.
How much is BioQuest Corp worth?
The market values BioQuest Corp at about $2.0M (market capitalisation, as of Jun 24, 2026). Per share that is $0.0670; our models calculate a fair value of $0.0300 per share.
What do the bullish and bearish scenarios say about BQST?
Our models span a range for BioQuest Corp: cautious scenario $0.0200, base $0.0300, optimistic $0.0400 per share (as of Jun 24, 2026, price $0.0670). The range comes from different growth and margin assumptions, not from analyst opinions.
How far is BQST from its 52-week high?
BioQuest Corp trades at $0.0670, about 93% below its 52-week high of $1.00 and 2% above the low of $0.0660 (as of Sep 18, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0300 is for.
Which stocks are comparable to BioQuest Corp?
From the same area (Financial Services) we also value Lionheart III Corp, AA Mission Acquisition Corp, Berto Acquisition Corp, Metals Acquisition Corp, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is BioQuest Corp stock attractive at the current price?
The data as of Jun 24, 2026: price $0.0670, calculated fair value $0.0300 (−55%), Quality Score 31/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of BQST calculated?
We run BioQuest Corp through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0300, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. BioQuest Corp itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of BioQuest Corp (BQST)?
The latest price we hold is from Sep 18, 2026 and stands at $0.0670. Our model-based fair value is $0.0300, about −55% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with BioQuest Corp right now?
The price sits above even our optimistic bull case ($0.0400). The favourable scenario is already priced in. Weak quality (31/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. A fairly wide model range ($0.0200 to $0.0400) leaves room in how you read the outcome.

Key figures of BioQuest Corp

How large is the market capitalisation of BioQuest Corp (BQST)?
The market capitalisation of BioQuest Corp is $2.0M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of BioQuest Corp (BQST)?
The price-to-sales ratio of BioQuest Corp is 63.7 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the EBIT return on assets of BioQuest Corp (BQST)?
On an EBIT basis the return on assets of BioQuest Corp is −34,731% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
How much free cash flow does BioQuest Corp (BQST) generate?
The free cash flow of BioQuest Corp is −$746K (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does BioQuest Corp (BQST) carry?
The net debt of BioQuest Corp is $386K (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch BioQuest Corp in the live analysis

One click puts BioQuest Corp on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.